Vanguard Group »

Aprea Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Aprea Therapeutics (APRE) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Aprea Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aprea Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aprea Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $472k 116k 4.07
2024-03-31 $776k 116k 6.69
2023-12-31 $163k 35k 4.70
2023-09-30 $114k 27k 4.17
2023-06-30 $49k 16k 3.15
2023-03-31 $69k 16k 4.44